Prelude Capital Management, LLC Astrazeneca PLC Transaction History

Prelude Capital Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $734,698 - $1.88 Million	-13,857 Reduced 65.27%	7,372 $404,000
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $1.26 Million - $1.51 Million	21,229 New	21,229 $1.4 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $1 Million - $1.15 Million	-18,860 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $812,866 - $1.04 Million	18,860 New	18,860 $998,000
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $40,321 - $54,769	-1,067 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $511,133 - $607,437	-12,038 Reduced 91.86%	1,067 $53,000
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $467,999 - $530,407	11,665 Added 810.07%	13,105 $584,000
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $831,455 - $929,589	-22,303 Reduced 93.94%	1,440 $59,000
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $274,444 - $332,673	-7,733 Reduced 24.57%	23,743 $960,000
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $9,620 - $10,828	-261 Reduced 0.82%	31,476 $1.2 Million
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $378,397 - $432,391	10,886 Added 52.21%	31,737 $1.26 Million
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $6,633 - $7,113	192 Added 0.93%	20,851 $732,000
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $609,153 - $676,775	18,476 Added 846.36%	20,659 $722,000
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $15,178 - $16,450	473 Added 27.66%	2,183 $76,000
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $49,521 - $58,140	1,710	1,710 $58,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.